Brand competition, underpinned by intellectual property rights, is the key to ending the global fake medicines crisis.
When trademarks are difficult to enforce, poor quality copies will crowd out legitimate versions, with serious consequences for patients.
The paper also takes a critical look at the various technologies designed to combat fake medicines, including holograms, 2D and QR barcodes.
